Sources | Names Used |
---|---|
CTRPv2 | navitoclax:MST-312 (1:1 mol/mol) |
PharmacoGx | navitoclax:MST-312 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ESRRG | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ZNF461 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | SLC8A2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | DAND5 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
mRNA | CSRNP3 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |